PharmaShots | Incisive News in 3 Shots

Subscribe Now

VantAI

Boehringer Ingelheim Entered into a Research Agreement with VantAI to Identify Novel Protein Degraders

Boehringer Ingelheim Entered into a Research Agreement with VantAI to Identify Novel Protein Degraders

April 21, 2022

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us